Cytosolic phospholipase A2 and the distinct transcriptional programs of astrocytoma cells

被引:19
|
作者
Hernandez, M [1 ]
Nieto, ML
Crespo, MS
机构
[1] Univ Valladolid, CSIC, Inst Mol Biol & Genet, E-47005 Valladolid, Spain
[2] Univ Valladolid, Hosp Clin, Inst Ciencias Corazon, E-47005 Valladolid, Spain
关键词
D O I
10.1016/S0166-2236(00)01563-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Astrocytes constitute the most abundant cell type in the nervous system. Under physiological conditions, they respond to the stimuli to which neurons are also responsive. The use of astrocytoma cell lines with well-defined morphological and functional markers has been helpful for addressing the mechanisms of signal transduction that operate in the nervous system. On the basis of the effects produced by agonists of different types of receptor (muscarinic ACh receptors, thrombin receptors, phospholipases A(2) receptors and tumor necrosis factor alpha receptors), several different transcriptional programs that involve the MAP kinase-cytosolic phospholipase A(2) system and the transcription factor NF-kappa B have been described.
引用
收藏
页码:259 / 264
页数:6
相关论文
共 50 条
  • [31] Cytosolic phospholipase A2 as a mediator of disease pathogenesis
    Linkous, Amanda
    Yazlovitskaya, Eugenia
    CELLULAR MICROBIOLOGY, 2010, 12 (10) : 1369 - 1377
  • [32] The role of cytosolic phospholipase A2 in insulin secretion
    Jones, PM
    Burns, CJ
    Belin, VD
    Roderigo-Milne, HM
    Persaud, SJ
    DIABETES, 2004, 53 : S172 - S178
  • [33] Increased levels of cytosolic phospholipase A2 in dyslexics
    MacDonnell, LEF
    Skinner, FK
    Eward, PE
    Glen, AIM
    Glen, ACA
    Macdonald, DJ
    Boyle, RM
    Horrobin, DF
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2000, 63 (1-2): : 37 - 39
  • [34] Nuclear membrane mechanotransduction by cytosolic phospholipase A2
    Niethammer, P.
    Shen, Z.
    Belcheva, K. T.
    Jelcic, M.
    Hui, K.
    Katikaneni, A.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 99 - 99
  • [35] Recent advances in the regulation of cytosolic phospholipase A2
    Gijon, MA
    Spencer, DM
    Leslie, CC
    ADVANCES IN ENZYME REGULATION, VOL 40, 2000, 40 : 255 - 268
  • [36] Pyrrolidine inhibitors of human cytosolic phospholipase A2
    Seno, K
    Okuno, T
    Nishi, K
    Murakami, Y
    Watanabe, F
    Matsuura, T
    Wada, M
    Fujii, Y
    Yamada, M
    Ogawa, T
    Okada, T
    Hashizume, H
    Kii, M
    Hara, S
    Hagishita, S
    Nakamoto, S
    Yamada, K
    Chikazawa, Y
    Ueno, M
    Teshirogi, I
    Ono, T
    Ohtani, M
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (06) : 1041 - 1044
  • [37] Cytosolic Phospholipase A2 and Lysophospholipids in Tumor Angiogenesis
    Linkous, Amanda G.
    Yazlovitskaya, Eugenia M.
    Hallahan, Dennis E.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (18): : 1398 - 1412
  • [38] Cytosolic Phospholipase A2: A Drug Target in FSGS
    Erkan, Elif
    Chhaing, Richard
    Potter, Andrew
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 50 - 51
  • [39] Enzymatic properties of human cytosolic phospholipase A2γ
    Stewart, A
    Ghosh, M
    Spencer, DM
    Leslie, CC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (33) : 29526 - 29536
  • [40] Lung Kruppel-like factor (LKLF) is a transcriptional activator of the cytosolic phospholipase A2 α promoter
    Wick, MJ
    Blaine, S
    Van Putten, V
    Saavedra, M
    Nemenoff, RA
    BIOCHEMICAL JOURNAL, 2005, 387 : 239 - 246